AVITA Medical (RCEL) Non-Current Assets (2018 - 2025)
AVITA Medical (RCEL) posted Non-Current Assets of $20.9 million for Q4 2025, down 6.52% on a QoQ basis from $22.4 million in Q3 2025, and down 7.97% year-over-year from $22.7 million in Q4 2024.
AVITA Medical (RCEL) Non-Current Assets (2018 - 2025) Analysis & Trends
AVITA Medical's Non-Current Assets history runs 8 years deep, the most recent figure standing at $20.9 million for Q4 2025.
- Quarterly Non-Current Assets fell 7.97% year-over-year to $20.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $86.7 million (up 31.21% YoY) and the FY2025 annual result came in at $20.9 million, down 7.97% from the prior year.
- Non-Current Assets was $20.9 million for Q4 2025 at AVITA Medical, down from $22.4 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $24.0 million in Q3 2021 and bottomed at $4.2 million in Q2 2021.
- A 5-year average of $14.4 million and a median of $13.1 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2021 — Non-Current Assets soared 519.53% — and 2022, when it tumbled 65.84%.
- AVITA Medical's Non-Current Assets stood at $23.9 million in 2021, then sank by 54.75% to $10.8 million in 2022, then retreated by 29.35% to $7.6 million in 2023, then surged by 197.5% to $22.7 million in 2024, then fell by 7.97% to $20.9 million in 2025.
- Business Quant data shows RCEL's Non-Current Assets at $20.9 million in Q4 2025, $22.4 million in Q3 2025, and $21.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | 20.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.90 Mn |
| Sep 30, 2025 | 22.36 Mn |
| Jun 30, 2025 | 21.88 Mn |
| Mar 31, 2025 | 21.59 Mn |
| Dec 31, 2024 | 22.71 Mn |
| Sep 30, 2024 | 17.13 Mn |
| Jun 30, 2024 | 14.87 Mn |
| Mar 31, 2024 | 11.40 Mn |
| Dec 31, 2023 | 7.63 Mn |
| Sep 30, 2023 | 7.09 Mn |
| Jun 30, 2023 | 8.84 Mn |
| Mar 31, 2023 | 9.86 Mn |
| Dec 31, 2022 | 10.81 Mn |
| Sep 30, 2022 | 8.21 Mn |
| Jun 30, 2022 | 10.86 Mn |
| Mar 31, 2022 | 15.81 Mn |
| Dec 31, 2021 | 23.88 Mn |
| Sep 30, 2021 | 24.04 Mn |
| Jun 30, 2021 | 4.17 Mn |
| Mar 31, 2021 | 4.38 Mn |